Treatment of severe steroid refractory acute graft versus host disease with Infliximab, a chimeric human/mouse anti-TNF-alpha antibody

被引：0
|
作者：
Kobbe, G
Schneider, P
Fenk, R
Rohr, U
Neumann, F
Aivado, M
Rong, A
Hünerlitürkoglu, A
Haas, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [1] Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody
    Kobbe, G
    Schneider, P
    Rohr, U
    Fenk, R
    Neumann, F
    Aivado, M
    Dietze, L
    Kronenwett, R
    Hünerlitürkoglu, A
    Haas, R
    BONE MARROW TRANSPLANTATION, 2001, 28 (01) : 47 - 49
  • [2] Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody
    G Kobbe
    P Schneider
    U Rohr
    R Fenk
    F Neumann
    M Aivado
    L Dietze
    R Kronenwett
    A Hünerlitürkoglu
    R Haas
    Bone Marrow Transplantation, 2001, 28 : 47 - 49
  • [3] Treatment of severe steroid refractory acute graft versus host disease with infliximab.
    Magalhaes-Silverman, M
    Lee, CK
    Hohl, R
    Becker, A
    Gingrich, R
    BLOOD, 2001, 98 (11) : 359B - 359B
  • [4] Anti TNF-alpha antibody in the treatment of severe acute graft versus host disease
    Fuchs, M
    Waldschmidt, D
    Scheid, C
    Diehl, V
    Soehngen, D
    BONE MARROW TRANSPLANTATION, 2002, 29 : S182 - S182
  • [5] Infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease.
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Skert, C
    Morreale, G
    Dini, G
    Bandini, G
    Milone, G
    Corradini, P
    Peccatori, J
    Fanin, R
    Bosi, A
    Bacigalupo, A
    BLOOD, 2003, 102 (11) : 451B - 451B
  • [6] Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease
    Trenschel, R
    Trampenau, C
    Ditschkowski, M
    Elmaagacli, A
    Ottinger, H
    Steckel, N
    Biersack, H
    Peceny, R
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S128 - S129
  • [7] Anti TNF-α antibody in the treatment of severe acute graft versus host disease.
    Fuchs, M
    Waldschmidt, DT
    Scheid, C
    Diehl, V
    Soehngen, D
    BLOOD, 2001, 98 (11) : 356B - 357B
  • [8] Treatment of refractory posterior uveitis with anti-TNF-alpha (infliximab).
    Banares, A
    Abasolo, I
    Macarron, P
    Hernandez, C
    Jover, JA
    Fernandez, B
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S90 - S90
  • [9] Treatment of a severe case of Bechat's disease with anti-TNF-alpha: Infliximab
    Andreu, M
    Ramanoelina, J
    Fajnkuchen, F
    Mouthon, L
    Cohen, P
    Laroche, L
    Guillevin, L
    ANNALES DE MEDECINE INTERNE, 2002, 153 (06): : 414 - 415
  • [10] Infliximab as treatment for steroid refractory acute and chronic graft-versus-host disease.
    Trenschel, R
    Ditschkowski, M
    Biersack, H
    Trampenau, C
    Steckel, NK
    Peceny, R
    Ottinger, H
    Elmaagacli, A
    Scheulen, ME
    Beelen, DW
    Schaefer, UW
    BLOOD, 2002, 100 (11) : 450B - 450B
12345